Intrinsiqs

Is Whitehawk Therapeutics Inc overvalued?

Whitehawk Therapeutics Inc (WHWK) — key valuation metrics and fundamentals.

No verdict
Price
$3.76
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$214.4M
Dividend yield
0.0%
Return on equity
-53.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares WHWK's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.